The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

Data suggest that states with strict abortion bans are losing residents, particularly younger people, which could have long-term economic implications.

Amid heightened tensions between the United States and China, the two countries last month signed a bilateral science and technology agreement. The event was billed as a “renewal” of a 45-year-old ...

The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

Physicians have a duty of care, which includes calling for payer reform and ending practices that are killing patients, ...

Caroline Wagner is a professor of public affairs at The Ohio State University. She receives funding from SECURE, a research security service funded by the National Science Foundat ...

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

Female firefighters have an increased risk of breast, ovarian, and uterine cancers. Now, thanks to a policy change, any federal firefighter diagnosed with these cancers who has worked for at least 5 ...

After ProPublica reported on a health insurer that refused to cover the only medicine that could save a cancer patient’s life, Michigan insurance regulators clarified that, by law, many plans must pay ...

The ASIR (per 100,000 person-years) of testicular germ cell tumors increased from 4.71 in 1992 to 6.22 in 2021, for an average annual percent change (AAPC) of 0.92%. The ASIR of seminoma increased ...

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

Obesity at childhood cancer diagnosis was independently associated with inferior survival, and this was likely driven by trends detected in children with acute lymphoblastic leukemia or central ...